147 related articles for article (PubMed ID: 17217203)
1. [Effects of nootropic agents on visual functions and lacrimal antioxidative activity in patients with primary open-angle glaucoma].
Davydova NG; Kuznetsova TP; Borisova SA; Abdulkadyrova MZh
Vestn Oftalmol; 2006; 122(6):42-5. PubMed ID: 17217203
[TBL] [Abstract][Full Text] [Related]
2. [Effect of pantogam on visual function and hemodynamic of eyes in patients with primary open-angle glaucoma].
Davydova NG; Borisova SA; Kolomoĭtseva EM; Abdulkadyrova MZh; Gorshkova IA; Lisitsyna SV
Vestn Oftalmol; 2002; 118(5):3-5. PubMed ID: 12532734
[TBL] [Abstract][Full Text] [Related]
3. [Results of pikamilon use in the treatment of patients with open-angle glaucoma].
Kolomoĭtseva EM; Ermakova VN; Abdulkadyrova MZh
Vestn Oftalmol; 1994; 110(4):4-7. PubMed ID: 7871655
[TBL] [Abstract][Full Text] [Related]
4. [Psychophysiological effects of combined administration of pantogam and potassium orotate in patients with neurotic disorders].
Ben'kovich BI; Gorshkova IA; Gershanovich II; Faĭzulloev AZ
Eksp Klin Farmakol; 2001; 64(3):26-8. PubMed ID: 11558433
[TBL] [Abstract][Full Text] [Related]
5. [Pantogam in daily psychiatric practice].
Kontsevoĭ VA; Rotshteĭn VG; Bogdan MN; Riakhovskiĭ VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):34-9. PubMed ID: 18427457
[TBL] [Abstract][Full Text] [Related]
6. [Comparative investigation of calcium ketopantoylaminobutyrate and pantogam: tranquilizer activity].
Karaev AL; Kozlova GS; Smirnova TN; Gunar VI
Eksp Klin Farmakol; 2004; 67(6):20-2. PubMed ID: 15707008
[TBL] [Abstract][Full Text] [Related]
7. [Pantogam in the treatment of patients with organic brain lesions of different genesis].
Rogacheva TA; Mel'nikova TS; Krasnoslobodtseva LA; Nazmetdinova DM; Lapin IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):34-9. PubMed ID: 21183912
[TBL] [Abstract][Full Text] [Related]
8. [The antioxidant activity of the lacrimal fluid in patients with primary open-angle glaucoma].
Makashova NV; Babenkova IV; Teselkin IuO
Vestn Oftalmol; 1999; 115(5):3-4. PubMed ID: 10582007
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological effects and clinical application of pantogam and pantogam active].
Voronina TA; Litvinova SA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):132-139. PubMed ID: 28884730
[TBL] [Abstract][Full Text] [Related]
10. [The effect of lipoic acid on the components of the glutathione system in the lacrimal fluid of patients with open-angle glaucoma].
Filina AA; Davydova NG; Kolomoĭtseva EM
Vestn Oftalmol; 1993; 109(5):5-7. PubMed ID: 7906064
[TBL] [Abstract][Full Text] [Related]
11. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of pantogam in the treatment of hyperkinetic disorders in children].
Sukhotina NK; Konovalova VV; Kryzhanovskaia IL; Kupriianova TA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):24-8. PubMed ID: 21311483
[TBL] [Abstract][Full Text] [Related]
13. [The role of combat stress in the development of chronic pain syndrom in veterans and its treatment by pantogam active].
Pal'tsev AI; Torgashov MN; Vorontsova IuS; Baiandina EV; Luniakina SB
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):43-6. PubMed ID: 21246890
[No Abstract] [Full Text] [Related]
14. [Pharmacokinetics of hopantenic acid upon peroral administration].
Karlina MV; Pozharitskaia ON; Kosman VM; Shikov AN; Lazukina MA; D'iachuk GI
Eksp Klin Farmakol; 2010 Aug; 73(8):46-8. PubMed ID: 20919560
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and tolerability of pantogam activ in patients with partial epilepsy].
Poverennova IE; Iakunina AV; Kalinin VA; Savel'eva NN
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2):54-9. PubMed ID: 21350425
[TBL] [Abstract][Full Text] [Related]
16. [Effect of local hypotensives on the eye microcirculation in initial open-angle glaucoma].
Kurov VV
Oftalmol Zh; 1982; 37(8):465-8. PubMed ID: 7162738
[No Abstract] [Full Text] [Related]
17. [Preventive and cessation therapy of mental disorders in patients with the acute coronary syndrome].
Medvedev VE; Epifanov AV; Zverev KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):42-8. PubMed ID: 22810740
[TBL] [Abstract][Full Text] [Related]
18. [Antihypoxant and antiamnesic effects of calcium ketopantoylaminobutyrate].
Karavaev AL; Kozlova GS; Smirnova TN; Gunar VI
Eksp Klin Farmakol; 2005; 68(6):9-11. PubMed ID: 16405026
[TBL] [Abstract][Full Text] [Related]
19. [New possibilities of pharmacotherapy in cardiovascular patients with mental disorders].
Medvedev VE; Frolova VI; Epifanov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):30-7. PubMed ID: 25403298
[TBL] [Abstract][Full Text] [Related]
20. [The use of biologically controlled ultrasound therapy for the combined treatment of primary open-angle glaucoma].
Novikova EG; Baranov VI
Vopr Kurortol Fizioter Lech Fiz Kult; 2010; (5):33-5. PubMed ID: 21328903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
